21/314US=23-E / Câncer
Boylan KLM, Skubitz KM, Skubitz APN. Subgroups of ovarian carcinoma: identification using differential gene expression. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 35-58. ISBN 978-90-481-2917-1.

CANCER DO OVARIO; CARCINOMA DE OVARIO


22/314US=23-E / Câncer
Sur M, Daya D. Sertolifrom: endometrioid carcinoma of the ovary: diagnosis and prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 59-68. ISBN 978-90-481-2917-1.

SERTOLIFROM; CARCINOMA DO OVARIO; ENDOMETRIOID; CARCINOMA DO OVARIO. DIAGNOSTICO; CARCINOMA DO OVARIO. TRATAMENTO


23/314US=23-F / Câncer
MacKeigan JP, Gaither LA. Role of RNA interference in understanding the molecular basis of cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 5-20. ISBN 978-90-481-3185-3.

CANCER DE CABECA E PESCOCO; CANCER DE TIREOIDE; CANCER. TRATAMENTO; CANCER . DIAGNOSTICO; CANCER. TERAPIA


24/314US=23-E / Câncer
Gubbels JAA, Connor JP, Patankar MS. Role of MUC16 (CA125) in the pathogenesis of epithelial ovarian cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 71-84. ISBN 978-90-481-2917-1.

MUC16; CA125 NA PATOGENESE DO CANCER EPITELIAL DE OVARIO; CANCER EPITELIAL DE OVARIO; CAMADAS DE DEFESA DO TUMOR DAS CELULAS


25/314US=23-F / Câncer
Cho WCS. Cancer biomarkers (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 21-40. ISBN 978-90-481-3185-3.

BIOMARCADORES DE CANCER


26/314US=23-E / Câncer
Takano M, Sasaki N, Sugiyama T. Clear cell carcinoma of the ovary: prognosis using cytoreductive surgery. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 85-91. ISBN 978-90-481-2917-1.

CARCINOMA DE CELULAS CLARAS DO OVARIO; CIRURGIA CITOSTATICA


27/314US=23-F / Câncer
Tokunaga O, Minhajat R, Mori D. Tumor angiogenesis in cancers: expression of CD105 marker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 41-50. ISBN 978-90-481-3185-3.

ANGIOGENESE TUMORAL NO CANCER; MARCADORES ANGIOGENICOS CD105


28/314US=23-F / Câncer
Vajtai I, Sahli R. Spindle cell oncocytoma of the adenohysis: integrated clinicopathologic diagnosis by imaging, histology, and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 51-7. ISBN 978-90-481-3185-3.

ONCOCITOMA; CELULAS FUSIFORMES DO ADENOHYSIS


29/314US=23-F / Câncer
Sève P, Mackey JR. Disseminated carcinoma of unknown primary site: detection with f-fluorodeoxyglucose-positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 59-71. ISBN 978-90-481-3185-3.

CARCINOMA PRIMARIO; DETECCAO COM F-FLUORODESOXIGLICOSE-TOMOGRAFIA


30/314US=23-F / Câncer
Yasuda I. Unknown lymphadenopathy: diagnosing using an endoscopic ultrasound-guided fine-needle aspiration biopsy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 73-8. ISBN 978-90-481-3185-3.

LINFADENOPATIA DESCONHECIDO; ENDOSCOPICA ASPIRACAO COM AGULHA FINA BIOPSIA


31/314US=23-E / Câncer
Dowdy SC, Cliby WA. Advanced ovarian cancer: prediction of surgical outcomes using computed tomograpy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 93-103. ISBN 978-90-481-2917-1.

CANCER DE OVARIO AVANCADO; RESULTADOS CIRURGICOS; CITORREDUCAO


32/314US=23-F / Câncer
Papi S, Grana CM, Bartolomei M, Ravasi L, Cremonesi M, Ferrari M, Martano L, Garaboldi L, Chinol M, Paganelli G. Pretargeted radioimmunotherapy in cancer: an overview. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 81-98. ISBN 978-90-481-3185-3.

RADIOIMUNOTERAPIA; RADIOIMUNOTERAPIA PRETARGETED NO CANCER


33/314US=23-E / Câncer
Merkle EM, Nelson RC, Lewin JS. Renal cell carcinoma: follow-up with magnetic resonance imaging after percutaneous radiofrequency ablation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 109-13. ISBN 978-90-481-2917-1.

CARCINOMA DE CELULAS RENAIS; RESSONANCIA MAGNETICA APOS ABLACAO; RADIOFREQUENCIA PERCUTANEA; TUMOR RESIDUAL OU RECORRENTE


34/314US=23-F / Câncer
Park SB, Kiernan MC. Chemotherapy-induced neurotoxicity. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 99-119. ISBN 978-90-481-3185-3.

NEUROTOXICIDADE INDUZIDA POR QUIMIOTERAPIA


35/314US=23-F / Câncer
Yague E, Raguz S. Multidrug resistance. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 121-33. ISBN 978-90-481-3185-3.

RESISTENCIA A MULTIPLAS DROGAS; QUIMIOTERAPIA TRADICIONAL; CANCER DE CELULAS-TRONCO. RESISTENCIA AS DROGAS


36/314US=23-E / Câncer
Quan JR WDY, Quan FM. Metastatic kidney cancer: treatment with infusional interleukin-2 plus famotidine. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 115-20. ISBN 978-90-481-2917-1.

CANCER RENAL METASTATICO; TRATAMENTO COM INFUSAO DE INTERLEUCINA-2


37/314US=23-E / Câncer
Klatte T, Böhm M. Renal cell carcinoma: preoperative treatment with cytokines followed by surgery. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 121-35. ISBN 978-90-481-2917-1.

CARCINOMA DE CELULAS RENAIS; TRATAMENTO PRE-OPERATORIO COM CITOCINAS


38/314US=23-E / Câncer
Tomita Y, Maruyama R, Itoi T, Bilim V. Metastatic renal cell carcinoma: use of Bcl-2 and Fas to predict responses to immunotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 137-45. ISBN 978-90-481-2917-1.

CARCINOMA; METASTATICO DE CELULAS RENAIS; BCL-2 E FAS; IMUNOTERAPIA


39/314US=23-E / Câncer
Ozluk Y. Wilms tumor: prognosis using microvessel density. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 147-55. ISBN 978-90-481-2917-1.

TUMOR DE WILMS; DENSIDADE MICROVASCULAR. PROGNOSTICO; ANGIOGENESE


40/314US=23-E / Câncer
Burel-Vandenbos F, Cardot-Leccia N, Haudebourg J, Ambrosetti D, Michiels JF. Adenomatoid tumor of the adrenal gland: differential diagnosis using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 161-65. ISBN 978-90-481-2917-1.

TUMOR ADENOMATOIDE DA GLANDULA SUPRA-RENAL; DIAGNOSTICO COM IMUNOISTOQUIMICA; IMUNOFENOTIPO


Primeira | Anterior | Próxima | Última